abstract |
The present invention relates to the a2b modified interferon with Y-reamified polyethylene glycol (PEG) in a simple residue of Lys and the preparation thereof. The pegylated IFN / a2b can be used for the preparation of a medicament for the treatment of a disease, for example, viral infections such as hepatitis C. |